Loading...

Sharof Tugizov, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Phone415-514-3177
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral StudiesGraduate Division

    Collapse Overview 
    Collapse Overview
    A goal of my laboratory is to understand the molecular mechanisms of the interactions of human viruses, including human immunodeficiency virus and herpes viruses with oropharyngeal and anogenital mucosal epithelia. Specifically, we investigate the molecular mechanisms of transepithelial transmission of these viruses through the mucosal epithelium. Understanding viral transmission via the mucosal epithelium is important for preventing the initial steps of viral infection.

    Collapse Research 
    Collapse Research Activities and Funding
    Role of HIV in acceleration of HPV malignancy
    NIH/NCI R01CA232887Dec 1, 2018 - Nov 30, 2023
    Role: Principal Investigator
    Role of oral herpesvirus microbiota in pathogenesis of HIV mother to child transmission
    NIH/NIDCR R01DE028129Sep 6, 2018 - Jun 30, 2023
    Role: Principal Investigator
    Molecular mechanisms of oral HIV transmission modeling MTCT
    NIH/NIDCR R01DE023315May 1, 2013 - Mar 31, 2018
    Role: Principal Investigator
    HIV transcellular and transsynaptic penetration of mucosal epithelium
    NIH/NIDCR R21DE021011Jul 2, 2010 - Jun 30, 2013
    Role: Principal Investigator
    HIV AND EBV INTERACTION IN ORAL MUCOSAL EPITHELIUM
    NIH/NIDCR R21DE016009Mar 15, 2004 - Feb 28, 2007
    Role: Principal Investigator
    EBV BMRF-2 Protein in Infection of Oral Epithelial Cells
    NIH/NIDCR R01DE014894Jul 10, 2003 - Apr 30, 2010
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Global Health
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Walhart T, Isaacson-Wechsler E, Ang KH, Arkin M, Tugizov S, Palefsky JM. A Cell-Based Renilla Luminescence Reporter Plasmid Assay for High-Throughput Screening to Identify Novel FDA-Approved Drug Inhibitors of HPV-16 Infection. SLAS Discov. 2019 Jul 30; 2472555219860771. PMID: 31361520.
      View in: PubMed
    2. Wechsler EI, Tugizov S, Herrera R, Costa MD, Palefsky JM. Erratum: E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. J Gen Virol. 2018 07; 99(7):948. PMID: 29966543.
      View in: PubMed
    3. Sufiawati I, Tugizov SM. HIV-induced matrix metalloproteinase-9 activation through mitogen-activated protein kinase signalling promotes HSV-1 cell-to-cell spread in oral epithelial cells. J Gen Virol. 2018 07; 99(7):937-947. PMID: 29775175.
      View in: PubMed
    4. Wechsler EI, Tugizov S, Herrera R, Da Costa M, Palefsky JM. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line. J Gen Virol. 2018 05; 99(5):631-644. PMID: 29624161.
      View in: PubMed
    5. Yasen A, Herrera R, Rosbe K, Lien K, Tugizov SM. HIV internalization into oral and genital epithelial cells by endocytosis and macropinocytosis leads to viral sequestration in the vesicles. Virology. 2018 02; 515:92-107. PMID: 29277006.
      View in: PubMed
    6. Yasen A, Herrera R, Rosbe K, Lien K, Tugizov SM. Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction. PLoS Pathog. 2017 02; 13(2):e1006247. PMID: 28241053.
      View in: PubMed
    7. Haga T, Efird JT, Tugizov S, Palefsky JM. Increased TNF-alpha and sTNFR2 levels are associated with high-grade anal squamous intraepithelial lesions in HIV-positive patients with low CD4 level. Papillomavirus Res. 2017 Jun; 3:1-6. PMID: 28720441.
      View in: PubMed
    8. Tugizov S. Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease. Tissue Barriers. 2016 Jul-Sep; 4(3):e1159276. PMID: 27583187.
      View in: PubMed
    9. Herrera R, Morris M, Rosbe K, Feng Z, Weinberg A, Tugizov S. Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells. Virology. 2016 Jan; 487:172-87. PMID: 26539799.
      View in: PubMed
    10. Sufiawati I, Tugizov SM. HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One. 2014; 9(2):e88803. PMID: 24586397.
      View in: PubMed
    11. Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, Michael Berry J, Pilcher CD, Shiboski CH, Jay N, Rubin M, Chein A, Palefsky JM. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology. 2013 Nov; 446(1-2):378-88. PMID: 24074602.
      View in: PubMed
    12. Tugizov SM, Herrera R, Palefsky JM. Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol. 2013 Jul; 87(14):8179-94. PMID: 23698302.
      View in: PubMed
    13. Sharof M. Tugizov, Rossana Herrera, Piri Veluppillai, Deborah Greenspan, Joel M. Palefsky. 46. HIV-induced epithelial–mesenchymal transition in mucosal epithelium facilitates HPV paracellular penetration. Sexual Health. 2013 Jan 1; 10(6):592.
      View in: Publisher Site
    14. Erin Isaacson Wechsler, Sharof Tugizov, Joel Palefsky. 48. Cidofovir treatment prevents invasion of invasive HPV-16-positive anal keratinocytes. Sexual Health. 2013 Jan 1; 10(6):593.
      View in: Publisher Site
    15. . Sargeant, S. Deverasetty, Y. Luo, A. Villahoz-Baleta, S. Zobrist, V. Rathnayake, J. Russo, M. Muesing, M. Schiller, R. Andrabi, R. Kumar, M. Bala, A. Nair, A. Biswas, N. Wig, P. Kumar, K. Luthra, N. Gonzalez, K. McKee, E. Yuste, J.R. Mascola, J. Alcamí, L. Vojnov, M. Martins, A. Bean, M. Veloso de Santana, J. Sacha, N. Wilson, M. Bonaldo, R. Galler, M. Stevenson, D. Watkins, M. Aziz, M. Mata, F. Mahmood, H. Durkin, C. Liu, R. Greenblatt, M. Nowicki, E. Golub, K. Anastos, A. French, L. Baum, V.S. Wacleche, N. Chomont, A. Gosselin, P. Monteiro, M. Goupil, H. Kared, C. Tremblay, N. Bernard, M.-R. Boulassel, J.-P. Routy, P. Ancuta, J. Jadlowsky, C. Baiduc, M. Richardson, A. Bennett, B. Jakobsen, J.L. Riley, B. Vingert, D. Benati, O. Lambotte, P. de Truchis, L. Slama, P. Jeannin, S. Perez-Patrigeon, F. Boufassa, W.W. Kwok, F. Lemaître, J.-F. Delfraissy, J. Thèze, L.A. Chakrabarti, M. French, R. Center, K. Wilson, I. Fleyfel, S. Fernandez, A. Kelleher, P. An, J. Goedert, S. Donfield, S. Buchbinder, G. Kirk, R. Detels, C. Winkler, J. Lajoie, J. Juno, A. Burgener, S. Rahman, K. Mogk, C. Wachihi, J. Mwanjewe, F.A. Plummer, J. Kimani, T.B. Ball, K.R. Fowke, A. Burgener, J. Lajoie, C. Wachihi, J. Kimani, K. Fowke, F.A. Plummer, T.B. Ball, T.N. Dieye, A. Chentouffi, M. Camara, S. Sarr, M.V. Tran, M. Seydi, G. Dasgupta, M. Fall, G. Daneau, P.A. Diaw, L. Kestens, P.S. Sow, S. Mboup, L. Benmohamed, D.M. Asmuth, Z.-M. Ma, A. Albanese, S. Devaraj, E. Hodzic, J.-C. Garcia, T.H. Knight, N.M. Flynn, S. Mann, T. Yotter, E. Tsuchida, C.J. Miller, S. Pallikkuth, L. Micci, Z. Ende, R. Iriele, B. Cervasi, J. Else, G. Silvestri, F. Villinger, S. Pahwa, M. Paiardini, S. Solomon, K.G. Murugavel, R. Vignesh, D. Bella, R. Shoba, S. Poongulali, N. Kumarasamy, A. Landay, S.S. Solomon, C.R. Swathirajan, P. Balakrishnan, S. Cu-Uvin, K.H. Mayer, B.L. Shacklett, C.S. Palmer, J. Zhou, S. Saleh, L. Lam, A. Hearps, A. Maisa, C. Pereira, S. Lewin, A. Jaworowski, J.M. McCune, S. Crowe, G. Doitsh, N. Galloway, K. Monroe, Z. Yang, O. Zepeda, W.C. Greene, M. Patel, M.-A. Jenabian, B. Lebouché, M.-J. Brouillette, C. Tremblay, I. Kema, M.-R. Boulassel, J.-P. Routy, F. Al-Ghazawi, E. Faller, P. Parmar, J. Kakal, P. MacPherson, F. Al-Ghazawi, P. Parmar, E. Faller, S. Sugden, N. Sant, P. MacPherson, C. Vinton, J. Brenchley, B. Tabb, X.P. Hao, V.M. Hirsch, M. Paiardini, J. Lifson, G. Silvestri, J.D. Estes, F. Bushman, S. Sherrill-Mix, K. Ocwieja, R. Mukherjee, M. Brown, J. Chin, R. Custers-Allen, P. David, J. Olson, K. Travers, E. Schadt, M. Sánchez del Cojo, M.R. López-Huertas, E. Mateos, M. Coiras, J. Alcamí, G. Sampey, R. Van Duyne, I. Guendel, E. Gregg, N. Shafagati, M. Tyagi, R. Easely, Z. Klase, F. Romerio, M. Iglesias-Ussel, S. Nekhai, K. Kehn-Hall, F. Kashanchi, N. Kumar, V. Evans, S. Saleh, C.F. Pereira, P. Ellenberg, P.U. Cameron, S.R. Lewin, L. Gray, D. Cowley, E. Crespan, C. Welsh, C. Mackenzie, P. Gorry, S. Wesselingh, M. Churchill, M. Iglesias-Ussel, L. Marchionni, F. Romerio, S. Weber, H. Burger, K. Kemal, B. Weiser, K. Korn, K. Anastos, W. Doerfler, S. Saleh, D. Vatakis, P. Cameron, A. Harman, A. Cunningham, S. Lewin, D. Ma, A. Cillo, C.L. Xu, J. Kristoff, J. Fang, G. Haret-Richter, J. Mellors, I. Pandrea, C. Apetrei, B. Trinité, E. Ohlson, S. Rana, J. Alster, D.N. Levy, A.F.B. Victoriano, Y. Hibi, N. Tan Gana, K. Asamitsu, T. Okamoto, M. Marsden, M. Kovochich, N. Suree, S. Shimizu, R. Mehta, R. Cortado, G. Bristol, D.S. An, J. Zack, N. Madrid-Elena, B. Hernandez-Novoa, M. Lamas, L. Garcia-Bermejo, S. Moreno, T. Ruel, J. Achan, W. Huang, H. Cao, P. Li, L.A. Eller, M. Killian, E. Sinclair, E. Charlebois, D.V. Havlir, J. Wong, T.J. Henrich, G. Sciaranghella, J.Z. Li, S. Gallien, V. Ho, A.S. Lacasce, D.R. Kuritzkes, J. Lifson, G. Del Prete, R. Kiser, C.M. Trubey, J. Smedley, V. Coalter, K. Oswald, R. Shoemaker, R. Fast, Y. Li, A. Lara, A. Wiles, R. Wiles, R. Macallister, R. Sanchez, J. Wai, C. Tan, B. Keele, J. Estes, M. Piatakjr, D. Hazuda, J. Symons, S. Deeks. Track A Basic Science. Journal of the International AIDS Society. 2012 Oct 24; 15(Suppl 3):18438-01.
      View in: Publisher Site
    16. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol. 2012 Mar; 86(5):2556-70. PMID: 22205732.
      View in: PubMed
    17. Weinberg A, Naglik JR, Kohli A, Tugizov SM, Fidel PL, Liu Y, Herzberg M. Innate immunity including epithelial and nonspecific host factors: workshop 1B. Adv Dent Res. 2011 Apr; 23(1):122-9. PMID: 21441493.
      View in: PubMed
    18. Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011 Apr; 23(1):130-6. PMID: 21441494.
      View in: PubMed
    19. Challacombe SJ, Fidel PL, Tugizov S, Tao L, Wahl SM. HIV infection and specific mucosal immunity: workshop 4B. Adv Dent Res. 2011 Apr; 23(1):142-51. PMID: 21441496.
      View in: PubMed
    20. Tugizov SM, Herrera R, Veluppillai P, Greenspan D, Soros V, Greene WC, Levy JA, Palefsky JM. HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells. Virology. 2011 Jan 20; 409(2):211-22. PMID: 21056450.
      View in: PubMed
    21. Dorner M, Zucol F, Alessi D, Haerle SK, Bossart W, Weber M, Byland R, Bernasconi M, Berger C, Tugizov S, Speck RF, Nadal D. beta1 integrin expression increases susceptibility of memory B cells to Epstein-Barr virus infection. J Virol. 2010 Jul; 84(13):6667-77. PMID: 20427540.
      View in: PubMed
    22. Xiao J, Palefsky JM, Herrera R, Sunshine C, Tugizov SM. EBV-positive human sera contain antibodies against the EBV BMRF-2 protein. Virology. 2009 Oct 10; 393(1):151-9. PMID: 19698968.
      View in: PubMed
    23. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells. Virology. 2009 Jun 05; 388(2):335-43. PMID: 19394065.
      View in: PubMed
    24. Haga T, Uchide N, Tugizov S, Palefsky JM. Role of E-cadherin in the induction of apoptosis of HPV16-positive CaSki cervical cancer cells during multicellular tumor spheroid formation. Apoptosis. 2008 Jan; 13(1):97-108. PMID: 17906929.
      View in: PubMed
    25. Xiao J, Palefsky JM, Herrera R, Berline J, Tugizov SM. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells. Virology. 2008 Jan 20; 370(2):430-42. PMID: 17945327.
      View in: PubMed
    26. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, Palefsky JM. Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol. 2007 Jun; 81(11):5484-96. PMID: 17376918.
      View in: PubMed
    27. Xiao J, Palefsky JM, Herrera R, Tugizov SM. Characterization of the Epstein-Barr virus glycoprotein BMRF-2. Virology. 2007 Mar 15; 359(2):382-96. PMID: 17081581.
      View in: PubMed
    28. Tugizov S, Berline J, Herrera R, Penaranda ME, Nakagawa M, Palefsky J. Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex. J Virol. 2005 Jan; 79(2):1099-112. PMID: 15613338.
      View in: PubMed
    29. Sharof M. Tugizov, Jennifer W. Berline, Joel M. Palefsky. Erratum: Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine. 2003 Apr 1; 9(4):477-477.
      View in: Publisher Site
    30. Sharof M. Tugizov, Jennifer W. Berline, Joel M. Palefsky. Erratum: Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nature Medicine. 2003 Apr 1; 9(4):477-477.
      View in: Publisher Site
    31. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med. 2003 Mar; 9(3):307-14. PMID: 12592401.
      View in: PubMed
    32. Tugizov S, Maidji E, Xiao J, Pereira L. An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol. 1999 Oct; 73(10):8677-88. PMID: 10482621.
      View in: PubMed
    33. Tugizov S, Maidji E, Xiao J, Zheng Z, Pereira L. Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J Virol. 1998 Sep; 72(9):7374-86. PMID: 9696834.
      View in: PubMed
    34. Maidji E, Tugizov S, Abenes G, Jones T, Pereira L. A novel human cytomegalovirus glycoprotein, gpUS9, which promotes cell-to-cell spread in polarized epithelial cells, colocalizes with the cytoskeletal proteins E-cadherin and F-actin. J Virol. 1998 Jul; 72(7):5717-27. PMID: 9621030.
      View in: PubMed
    35. Navarro D, Lennette E, Tugizov S, Pereira L. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol. 1997 Aug; 52(4):451-9. PMID: 9260696.
      View in: PubMed
    36. Maidji E, Tugizov S, Jones T, Zheng Z, Pereira L. Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol. 1996 Dec; 70(12):8402-10. PMID: 8970961.
      View in: PubMed
    37. Zheng Z, Maidji E, Tugizov S, Pereira L. Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding. J Virol. 1996 Nov; 70(11):8029-40. PMID: 8892927.
      View in: PubMed
    38. Tugizov S, Maidji E, Pereira L. Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells. J Gen Virol. 1996 Jan; 77 ( Pt 1):61-74. PMID: 8558129.
      View in: PubMed
    39. Tugizov S, Wang Y, Qadri I, Navarro D, Maidji E, Pereira L. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology. 1995 Jun 01; 209(2):580-91. PMID: 7778290.
      View in: PubMed
    40. Ramakrishnan M, Tugizov S, Pereira L, Lee AS. Conformation-defective herpes simplex virus 1 glycoprotein B activates the promoter of the grp94 gene that codes for the 94-kD stress protein in the endoplasmic reticulum. DNA Cell Biol. 1995 May; 14(5):373-84. PMID: 7748487.
      View in: PubMed
    41. Pereira L, Maidji E, Tugizov S, Jones T. Deletion mutants in human cytomegalovirus glycoprotein US9 are impaired in cell-cell transmission and in altering tight junctions of polarized human retinal pigment epithelial cells. Scand J Infect Dis Suppl. 1995; 99:82-7. PMID: 8668948.
      View in: PubMed
    42. Tugizov S, Navarro D, Paz P, Wang Y, Qadri I, Pereira L. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology. 1994 Jun; 201(2):263-76. PMID: 8184537.
      View in: PubMed
    43. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology. 1993 Nov; 197(1):143-58. PMID: 7692667.
      View in: PubMed
    44. Tugizov SM, Savchenkova IP, Grabovskaya IL, Makarova NE, Eraizer TL, Revazova EP, Kushch AA. Changes in expression of surface and core antigens of hepatitis B virus in different mutant clones of hepatoma PLC-PRF-5 cells. Virus Res. 1993 Nov; 30(2):189-203. PMID: 8249446.
      View in: PubMed
    45. Grabovskaya IL, Tugizov SM, Glukhova LA, Kushch AA. Cytogenetic analysis of human hepatocarcinoma cell line PLC-PRF-5 and its mutant clones with different degrees of cell differentiation. Cancer Genet Cytogenet. 1993 Feb; 65(2):147-51. PMID: 8384075.
      View in: PubMed
    46. Kushch AA, Tugizov ShM, Terletskaia EN, Posevaia TA, Nikitina AA, L'vov ND, Barinskii IF. [Human hybridoma neutralizing antibodies to the herpes simplex virus]. Vopr Virusol. 1992 Sep-Dec; 37(5-6):264-6. PMID: 1337804.
      View in: PubMed
    47. Tugizov ShM, Savchenkova IP, Grabovskaia IL, Kushch AA. [Changes in the gene expression of the hepatitis B virus in PLC-PRF-5 cells of human hepatocarcinoma during their acquisition of drug resistance]. Vopr Virusol. 1992 Sep-Dec; 37(5-6):238-41. PMID: 1337803.
      View in: PubMed
    48. Shumai EP, Vorob'ev SM, Makarova NE, Tugizov ShM, Zverev VV, Kushch AA. [The immunoenzyme detection of the HIV-1 antigen by using monoclonal antibodies to protein p24]. Vopr Virusol. 1992 Sep-Dec; 37(5-6):229-32. PMID: 1290220.
      View in: PubMed
    49. El'bert LB, Vorovich MF, Terletskaia EN, Lisitsina EA, Atanadze SN, Sidorovich IG, Khozinskii VV, Tugizov ShM, Kushch AA, Khapchaev IuKh. [The protective activity of preparations made from the tick-borne encephalitis virus grown using different cell cultures]. Zh Mikrobiol Epidemiol Immunobiol. 1992 Jan; (1):25-8. PMID: 1414102.
      View in: PubMed
    50. Filatov FP, Tugizov ShM, Savchenkova IP, Kumarev VP, Belikov AS, Kadoshnikov IuP, Kush AA, Uryvaev LV. [Recombinant surface proteins of the hepatitis B virus, exhibiting the immunodominant membrane protein of the HIV-1 virus]. Dokl Akad Nauk. 1992; 327(1):172-5. PMID: 1486344.
      View in: PubMed
    51. Shpilevaia MV, Tugizov ShM, Kushch AA, Tsilinskii IaIa, Makarova NE. [The biological and immunochemical properties of monoclonal antibodies to the Venezuelan equine encephalomyelitis virus]. Vopr Virusol. 1991 Nov-Dec; 36(6):495-8. PMID: 1723821.
      View in: PubMed
    52. Kushch AA, Tugizov ShM, Simonov VI, Timofeev IV, Perminova NP, Shumai EP. [The properties of monoclonal antibodies to HIV gag gene proteins]. Vopr Virusol. 1991 Jul-Aug; 36(4):275-7. PMID: 1796579.
      View in: PubMed
    53. Vorovitch MF, Timofeev AV, Atanadze SN, Tugizov SM, Kushch AA, Elbert LB. pH-dependent fusion of tick-borne encephalitis virus with artificial membranes. Arch Virol. 1991; 118(1-2):133-8. PMID: 2048972.
      View in: PubMed
    54. Vorovich MF, Timofeev AV, Atanadze SN, Tugizov ShM, Sidorovich IG, Khozinskii VV, Kushch AA, El'bert LB. [The inhibition of the pH-dependent fusion of the tick-borne encephalitis virus with artificial membranes by using non-neutralizing monoclonal antibodies]. Dokl Akad Nauk SSSR. 1991; 316(1):231-4. PMID: 2055152.
      View in: PubMed
    55. Kushch AA, Beliavskii AV, Shumai EP, Tugizov ShM, Ovcharenko AV. [Monoclonal antibodies against topoisomerase I inhibit cell entering into the phase of DNA synthesis]. Dokl Akad Nauk SSSR. 1988; 300(4):968-71. PMID: 2844486.
      View in: PubMed